Showing results (151-160 of 313) with videos related to

Sort By:
Pageof 32
Diabetes Care|December 4, 2020
Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICTMuhammad Abdul-Ghani, Curtiss Puckett, John Adams, et al.
Obesity (Silver Spring, Md.)|April 12, 2007
Association of neuropeptide Y receptor Y5 polymorphisms with dyslipidemia in Mexican AmericansDawn K Coletta, Jennifer Schneider, Michael P Stern, et al.
Diabetes Care|January 19, 2017
Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar StudyMuhammad Abdul-Ghani, Osama Migahid, Ayman Megahed, et al.
Diabetes|December 25, 2003
Ceramide content is increased in skeletal muscle from obese insulin-resistant humansJohn M Adams, Thongchai Pratipanawatr, Rachele Berria, et al.
BMJ Open Diabetes Research & Care|April 27, 2025
Glycemic and non-glycemic benefits of initial triple therapy versus sequential add-on therapy in patients with new-onset diabetes: results from the EDICT studyMuhammad Abdul-Ghani, Curtiss Puckett, Siham Abdelgani, et al.
Endocrinology, Diabetes & Metabolism|March 1, 2019
Slope of change in HbA<sub>1c</sub> from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetesRalph A DeFronzo, Ele Ferrannini, Guntram Schernthaner, et al.
Diabetes|October 27, 2005
Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patientsMandeep Bajaj, Swangjit Suraamornkul, Anthony Romanelli, et al.
Diabetes Care|October 27, 2006
Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylureaCurtis Triplitt, Leonard Glass, Yoshiniro Miyazaki, et al.
Diabetes, Obesity & Metabolism|November 28, 2024
Effect of dapagliflozin on renal haemodynamics in hyperfiltering T2D patientsEugenio Cersosimo, Qin YueJuan, Gozde Baskoy, et al.
Cell Metabolism|July 4, 2006
Role of adiponectin in human skeletal muscle bioenergeticsAnthony E Civitarese, Barbara Ukropcova, Stacy Carling, et al.
Pageof 32